Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040560891> ?p ?o ?g. }
- W2040560891 abstract "To support a review of the guidance issued by the National Institute for Health and Clinical Excellence (NICE) in December 2000 by examining the current clinical and cost-effectiveness evidence on autologous cartilage transplantation.Electronic databases.Evidence on clinical effectiveness was obtained from randomised trials, supplemented by data from selected observational studies for longer term results, and for the natural history of chondral lesions. Because of a lack of long-term results on outcomes such as later osteoarthritis and knee replacement, only illustrative modelling was done, using a range of assumptions that seemed reasonable, but were not evidence based.Four randomised controlled trials were included, as well as observational data from case series. The trials studied a total of 266 patients and the observational studies up to 101 patients. Two studies compared autologous chondrocyte implantation (ACI) with mosaicplasty, the third compared ACI with microfracture, and the fourth compared matrix-guided ACI (MACI) with microfracture. Follow-up was 1 year in one study, and up to 3 years in the remaining three studies. The first trial of ACI versus mosaicplasty found that ACI gave better results than mosaicplasty at 1 year. Overall, 88% had excellent or good results with ACI versus 69% with mosaicplasty. About half of the biopsies after ACI showed hyaline cartilage. The second trial of ACI versus mosaicplasty found little difference in clinical outcomes at 2 years. Disappointingly, biopsies from the ACI group showed fibrocartilage rather than hyaline cartilage. The trial of ACI versus microfracture also found only small differences in outcomes at 2 years. Finally, the trial of MACI versus microfracture contained insufficient long-term results at present, but the study does show the feasibility of doing ACI by the MACI technique. It also suggested that after ACI, it takes 2 years for full-thickness cartilage to be produced. Reliable costs per quality-adjusted life-year (QALY) could not be calculated owing to the absence of necessary data. Simple short-term modelling suggests that the quality of life gain from ACI versus microfracture would have to be between 70 and 100% greater over 2 years for it to be more cost-effective within the 20,000--30,000 pounds sterling per QALY cost-effectiveness thresholds. However, if the quality of life gains could be maintained for a decade, increments relative to microfracture would only have to be 10--20% greater to justify additional treatment costs within the cost-effectiveness band indicated above. Follow-up from the trials so far has only been up to 2 years, with longer term outcomes being uncertain.There is insufficient evidence at present to say that ACI is cost-effective compared with microfracture or mosaicplasty. Longer term outcomes are required. Economic modelling using some assumptions about long-term outcomes that seem reasonable suggests that ACI would be cost-effective because it is more likely to produce hyaline cartilage, which is more likely to be durable and to prevent osteoarthritis in the longer term (e.g. 20 years). Further research is needed into earlier methods of predicting long-term results. Basic science research is also needed into factors that influence stem cells to become chondrocytes and to produce high-quality cartilage, as it may be possible to have more patients developing hyaline cartilage after microfracture. Study is also needed into cost-effective methods of rehabilitation and the effect of early mobilisation on cartilage growth." @default.
- W2040560891 created "2016-06-24" @default.
- W2040560891 creator A5004253626 @default.
- W2040560891 creator A5011358530 @default.
- W2040560891 creator A5023035949 @default.
- W2040560891 creator A5064282001 @default.
- W2040560891 creator A5067333950 @default.
- W2040560891 creator A5068981280 @default.
- W2040560891 creator A5076405762 @default.
- W2040560891 creator A5088628821 @default.
- W2040560891 date "2005-12-01" @default.
- W2040560891 modified "2023-10-17" @default.
- W2040560891 title "Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation" @default.
- W2040560891 cites W1242912298 @default.
- W2040560891 cites W141802151 @default.
- W2040560891 cites W14481853 @default.
- W2040560891 cites W152654618 @default.
- W2040560891 cites W1926917876 @default.
- W2040560891 cites W1988873510 @default.
- W2040560891 cites W1989706153 @default.
- W2040560891 cites W2000479459 @default.
- W2040560891 cites W2017910755 @default.
- W2040560891 cites W2028156877 @default.
- W2040560891 cites W2046913849 @default.
- W2040560891 cites W2047168130 @default.
- W2040560891 cites W2047646848 @default.
- W2040560891 cites W204981280 @default.
- W2040560891 cites W2052593694 @default.
- W2040560891 cites W2058060887 @default.
- W2040560891 cites W2074684646 @default.
- W2040560891 cites W2074895129 @default.
- W2040560891 cites W2082611998 @default.
- W2040560891 cites W2083225429 @default.
- W2040560891 cites W2112558297 @default.
- W2040560891 cites W2114904736 @default.
- W2040560891 cites W2122796410 @default.
- W2040560891 cites W2139048422 @default.
- W2040560891 cites W2257596590 @default.
- W2040560891 cites W2340316393 @default.
- W2040560891 cites W2403826742 @default.
- W2040560891 cites W2469475898 @default.
- W2040560891 cites W285021139 @default.
- W2040560891 doi "https://doi.org/10.3310/hta9470" @default.
- W2040560891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16336842" @default.
- W2040560891 hasPublicationYear "2005" @default.
- W2040560891 type Work @default.
- W2040560891 sameAs 2040560891 @default.
- W2040560891 citedByCount "185" @default.
- W2040560891 countsByYear W20405608912012 @default.
- W2040560891 countsByYear W20405608912013 @default.
- W2040560891 countsByYear W20405608912014 @default.
- W2040560891 countsByYear W20405608912015 @default.
- W2040560891 countsByYear W20405608912016 @default.
- W2040560891 countsByYear W20405608912017 @default.
- W2040560891 countsByYear W20405608912018 @default.
- W2040560891 countsByYear W20405608912019 @default.
- W2040560891 countsByYear W20405608912020 @default.
- W2040560891 countsByYear W20405608912021 @default.
- W2040560891 countsByYear W20405608912022 @default.
- W2040560891 countsByYear W20405608912023 @default.
- W2040560891 crossrefType "journal-article" @default.
- W2040560891 hasAuthorship W2040560891A5004253626 @default.
- W2040560891 hasAuthorship W2040560891A5011358530 @default.
- W2040560891 hasAuthorship W2040560891A5023035949 @default.
- W2040560891 hasAuthorship W2040560891A5064282001 @default.
- W2040560891 hasAuthorship W2040560891A5067333950 @default.
- W2040560891 hasAuthorship W2040560891A5068981280 @default.
- W2040560891 hasAuthorship W2040560891A5076405762 @default.
- W2040560891 hasAuthorship W2040560891A5088628821 @default.
- W2040560891 hasBestOaLocation W20405608911 @default.
- W2040560891 hasConcept C112930515 @default.
- W2040560891 hasConcept C126322002 @default.
- W2040560891 hasConcept C141071460 @default.
- W2040560891 hasConcept C142724271 @default.
- W2040560891 hasConcept C168563851 @default.
- W2040560891 hasConcept C204787440 @default.
- W2040560891 hasConcept C23131810 @default.
- W2040560891 hasConcept C2776164576 @default.
- W2040560891 hasConcept C2777870964 @default.
- W2040560891 hasConcept C2780024818 @default.
- W2040560891 hasConcept C2911091166 @default.
- W2040560891 hasConcept C3019080777 @default.
- W2040560891 hasConcept C3020332539 @default.
- W2040560891 hasConcept C535046627 @default.
- W2040560891 hasConcept C71924100 @default.
- W2040560891 hasConceptScore W2040560891C112930515 @default.
- W2040560891 hasConceptScore W2040560891C126322002 @default.
- W2040560891 hasConceptScore W2040560891C141071460 @default.
- W2040560891 hasConceptScore W2040560891C142724271 @default.
- W2040560891 hasConceptScore W2040560891C168563851 @default.
- W2040560891 hasConceptScore W2040560891C204787440 @default.
- W2040560891 hasConceptScore W2040560891C23131810 @default.
- W2040560891 hasConceptScore W2040560891C2776164576 @default.
- W2040560891 hasConceptScore W2040560891C2777870964 @default.
- W2040560891 hasConceptScore W2040560891C2780024818 @default.
- W2040560891 hasConceptScore W2040560891C2911091166 @default.
- W2040560891 hasConceptScore W2040560891C3019080777 @default.
- W2040560891 hasConceptScore W2040560891C3020332539 @default.
- W2040560891 hasConceptScore W2040560891C535046627 @default.
- W2040560891 hasConceptScore W2040560891C71924100 @default.